Bloomberg For the world’s leading Covid-19 vaccine makers, news that Merck & Co’s experimental pill cuts the risk of hospitalisation and death in half was the latest blow in a very bad week. Stocks including Moderna Inc and BioNTech SE have shed about $84 billion in combined value this week in the aftermath of a stock market slump that sent ...

Bloomberg Newly listed stocks provided a surprising source of gains during the US market’s worst month since March of 2020. Typically losers in a risk-off environment, New York’s initial public offerings (IPOs) instead delivered a rise of 25% on average during September’s selloff in the broader market. Consumer-facing stocks such as Dutch Bros Inc and On Holding AG that opted ...

Bloomberg Oil rises in tandem with equity markets while traders turned their attention to an upcoming Opec+ meeting that may yield supply increases. Futures in New York rise 1.1%. US benchmark crude posted a sixth straight weekly gain, the longest streak of weekly advances since early July. Buzz continued around whether on Monday Opec will decide to increase output after ...